Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 2
2003 1
2004 4
2005 5
2006 3
2007 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 1
2014 9
2015 4
2016 5
2017 6
2018 6
2019 9
2020 7
2021 7
2022 5
2023 3
2024 3
2025 1
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Patient acceptability of partial enteral nutrition as a concomitant therapy to Adalimumab in adults with active Crohn's disease - BIOPIC trial.
Fandinga C, Clowe J, White B, Campbell I, Seenan JP, Brownson E, Milling S, Koutsos A, Ho GT, Mowat C, Robertson E, Gaya DR, Kefayat A, Din S, MacDonald J, Gerasimidis K. Fandinga C, et al. Among authors: gaya dr. Ann Nutr Metab. 2026 May 19:1-18. doi: 10.1159/000551940. Online ahead of print. Ann Nutr Metab. 2026. PMID: 42154650 Free article.
Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial.
Quraishi MN, Moakes CA, Yalchin M, Blackwell C, Segal J, Ives NJ, Magill L, Manzoor SE, Gerasimidis K, McMullan C, Mathers J, Horniblow R, Loi S, Kaur M, Loman NJ, Sharma N, Hawkey P, McCune V, Quick J, Nicholls S, McMurray C, Nichols B, Svolos V, Raguideau S, Kerbiriou C, Oo YH, Beggs AD, Crees N, Hansen R, Hart AL, Gaya DR, Quince C, Iqbal TH. Quraishi MN, et al. Among authors: gaya dr. J Crohns Colitis. 2026 Mar 10;20(3):jjag006. doi: 10.1093/ecco-jcc/jjag006. J Crohns Colitis. 2026. PMID: 41587946 Free PMC article. Clinical Trial.
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.
Constantine-Cooke N, Gros B, Plevris N, Williams LJ, Jones GR, Kyle J, Kennedy NA, Velasco-Pardo V, Rudge A, Alexander D, Anderson CA, Brusco de Freitas M, Derr LM, Derikx LA, Gilchrist S, Henderson P, Horgan GW, Irving P, Lamb CA, Jostins-Dean L, Lindsay JO, MacDonald J, Mowat C, Murray C, Parkes M, Siakavellas SI, Vallejos CA, Gaya DR, Rhodes JM, Johnstone AM, Weir CJ, Lees CW; PREdiCCt study group. Constantine-Cooke N, et al. Among authors: gaya dr. Gut. 2026 Jul 8;75(8):1491-1504. doi: 10.1136/gutjnl-2025-337846. Gut. 2026. PMID: 41554630 Free article.
Inter- and Intraobserver Variability in Bowel Preparation Scoring for Colon Capsule Endoscopy: Impact of AI-Assisted Assessment Feasibility Study.
Lei II, Gaya DR, Robertson A, Schelde-Olesen B, Mapiye A, Bhandare A, Lui BB, Shekhar C, Valentiner U, Gilabert P, Laiz P, Segui S, Parsons N, Huhulea C, Wenzek H, White E, Koulaouzidis A, Arasaradnam RP. Lei II, et al. Among authors: gaya dr. Cancers (Basel). 2025 Aug 29;17(17):2840. doi: 10.3390/cancers17172840. Cancers (Basel). 2025. PMID: 40940936 Free PMC article.
Determining the optimal route of faecal microbiota transplant in patients with ulcerative colitis: the STOP-Colitis pilot RCT.
Quraishi MN, Moakes CA, Yalchin M, Segal J, Ives NJ, Magill L, Manzoor SE, Gerasimidis K, Loi S, McMullan C, Mathers J, Quince C, Kaur M, Loman NJ, Sharma N, Hawkey P, McCune V, Nichols B, Svolos V, Kerbiriou C, McMurray C, Beggs A, Hansen R, Hart AL, Gaya DR, Iqbal TH. Quraishi MN, et al. Among authors: gaya dr. Southampton (UK): National Institute for Health and Care Research; 2024 Aug. Southampton (UK): National Institute for Health and Care Research; 2024 Aug. PMID: 39250584 Free Books & Documents. Review.
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST.
Peyrin-Biroulet L, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravatà I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Danese S. Peyrin-Biroulet L, et al. Among authors: gaya dr. Aliment Pharmacol Ther. 2024 Jan;59(2):175-185. doi: 10.1111/apt.17751. Epub 2023 Nov 30. Aliment Pharmacol Ther. 2024. PMID: 38036946 Clinical Trial.
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.
Lim SH, Gros B, Sharma E, Lehmann A, Lindsay JO, Caulfield L, Gaya DR, Taylor J, Limdi J, Kwok J, Shuttleworth E, Dhar A, Burdge G, Selinger C, Cococcia S, Murray C, Balendran K, Raine T, George B, Walker G, Aldridge R, Irving P, Lees CW, Samaan M. Lim SH, et al. Among authors: gaya dr. Inflamm Bowel Dis. 2024 Aug 1;30(8):1284-1294. doi: 10.1093/ibd/izad166. Inflamm Bowel Dis. 2024. PMID: 37603730 Free article.
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial.
Panés J, Vermeire S, D'Haens GR, Danese S, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravatà I, Gaya DR, Peyrin-Biroulet L, Dignass A; STARDUST study group. Panés J, et al. Among authors: gaya dr. United European Gastroenterol J. 2023 Jun;11(5):410-422. doi: 10.1002/ueg2.12384. Epub 2023 May 4. United European Gastroenterol J. 2023. PMID: 37139642 Free PMC article. Clinical Trial.
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.
Chanchlani N, Lin S, Auth MK, Lee CL, Robbins H, Looi S, Murugesan SV, Riley T, Preston C, Stephenson S, Cardozo W, Sonwalkar SA, Allah-Ditta M, Mansfield L, Durai D, Baker M, London I, London E, Gupta S, Di Mambro A, Murphy A, Gaynor E, Jones KDJ, Claridge A, Sebastian S, Ramachandran S, Selinger CP, Borg-Bartolo SP, Knight P, Sprakes MB, Burton J, Kane P, Lupton S, Fletcher A, Gaya DR, Colbert R, Seenan JP, MacDonald J, Lynch L, McLachlan I, Shields S, Hansen R, Gervais L, Jere M, Akhtar M, Black K, Henderson P, Russell RK, Lees CW, Derikx LAAP, Lockett M, Betteridge F, De Silva A, Hussenbux A, Beckly J, Bendall O, Hart JW, Thomas A, Hamilton B, Gordon C, Chee D, McDonald TJ, Nice R, Parkinson M, Gardner-Thorpe H, Butterworth JR, Javed A, Al-Shakhshir S, Yadagiri R, Maher S, Pollok RCG, Ng T, Appiahene P, Donovan F, Lok J, Chandy R, Jagdish R, Baig D, Mahmood Z, Marsh L, Moss A, Abdulgader A, Kitchin A, Walker GJ, George B, Lim YH, Gulliver J, Bloom S, Theaker H, Carlson S, Cummings JRF, Livingstone R, Beale A, Carter JO, Bell A, Coulter A, Snook J, Stone H, Kennedy NA, Goodhand JR, Ahmad T; IMSAT study investigators. Chanchlani N, et al. Among authors: gaya dr. Aliment Pharmacol Ther. 2022 Oct;56(8):1250-1263. doi: 10.1111/apt.17170. Epub 2022 Aug 29. Aliment Pharmacol Ther. 2022. PMID: 36039036 Free PMC article.
84 results